Crossmark

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial

Crossref DOI link: https://doi.org/10.1186/s13104-019-4130-6

Published Online: 2019-02-15

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Darabi, Zahra

Darand, Mina

Yari, Zahra

Hedayati, Mehdi

Faghihi, Amirhosein

Agah, Shahram

Hekmatdoost, Azita https://orcid.org/0000-0002-1944-0052
Clinical Trials ^BETA

Clinical trials referenced in this document:

irct201703194010n18 at Iranian Registry of Clinical Trials

Documents that mention this clinical trial

Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial
https://doi.org/10.1186/s13104-019-4130-6
Funding

Funding for this research was provided by:

SBMU (6040)
License Information

Text and Data Mining valid from 2019-02-15

Version of Record valid from 2019-02-15
More Information

Article History

Received: 24 December 2018

Accepted: 11 February 2019

First Online: 15 February 2019

Document is current

Any future updates will be listed below